154 related articles for article (PubMed ID: 22614186)
21. The additive clinical value of 18F-FDG PET/CT in defining the recurrence of disease in patients with differentiated thyroid cancer who have isolated increased antithyroglobulin antibody levels.
Ozkan E; Soydal C; Araz M; Aras G; Ibis E
Clin Nucl Med; 2012 Aug; 37(8):755-8. PubMed ID: 22785502
[TBL] [Abstract][Full Text] [Related]
22. 18F-FDG SPECT/CT in the diagnosis of differentiated thyroid carcinoma with elevated thyroglobulin and negative iodine-131 scans.
Ma C; Wang X; Shao M; Zhao L; Jiawei X; Wu Z; Wang H
Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):220-7. PubMed ID: 24844253
[TBL] [Abstract][Full Text] [Related]
23. [The value of multimodal imaging by single photon emission computed tomography associated to X ray computed tomography (SPECT-CT) in the management of differentiated thyroid carcinoma: about 156 cases].
Mhiri A; El Bez I; Slim I; Meddeb I; Yeddes I; Ghezaiel M; Gritli S; Ben Slimène MF
Tunis Med; 2013 Oct; 91(10):589-93. PubMed ID: 24281999
[TBL] [Abstract][Full Text] [Related]
24. [SPECT/CT for staging and treatment monitoring in oncology. Applications in differentiated thyroid cancer and liver tumors].
Weber K; Berger F; Mustafa M; Reiser MF; Bartenstein P; Haug A
Radiologe; 2012 Jul; 52(7):646-52. PubMed ID: 22710988
[TBL] [Abstract][Full Text] [Related]
25. Clinical utility of 18F-FDG PET/CT concurrent with 131I therapy in intermediate-to-high-risk patients with differentiated thyroid cancer: dual-center experience with 286 patients.
Lee JW; Lee SM; Lee DH; Kim YJ
J Nucl Med; 2013 Aug; 54(8):1230-6. PubMed ID: 23813775
[TBL] [Abstract][Full Text] [Related]
26. ¹²⁴I PET/CT in the pretherapeutic staging of differentiated thyroid carcinoma: comparison with posttherapy ¹³¹I SPECT/CT.
de Pont C; Halders S; Bucerius J; Mottaghy F; Brans B
Eur J Nucl Med Mol Imaging; 2013 May; 40(5):693-700. PubMed ID: 23340593
[TBL] [Abstract][Full Text] [Related]
27. Role of Diagnostic
Spanu A; Nuvoli S; Gelo I; Mele L; Piras B; Madeddu G
J Nucl Med; 2018 Oct; 59(10):1510-1515. PubMed ID: 29496990
[TBL] [Abstract][Full Text] [Related]
28. Hybrid SPECT/CT Imaging in the Management of Differentiated Thyroid Carcinoma.
Ahmed N; Niyaz K; Borakati A; Marafi F; Birk R; Usmani S
Asian Pac J Cancer Prev; 2018 Feb; 19(2):303-308. PubMed ID: 29479949
[TBL] [Abstract][Full Text] [Related]
29. Incremental value of 99mTc-MDP hybrid SPECT/CT over planar scintigraphy and SPECT in avascular necrosis of the femoral head.
Agarwal KK; Mukherjee A; Sharma P; Bal C; Kumar R
Nucl Med Commun; 2015 Oct; 36(10):1055-62. PubMed ID: 26308940
[TBL] [Abstract][Full Text] [Related]
30. Can (18)F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?
Bannas P; Derlin T; Groth M; Apostolova I; Adam G; Mester J; Klutmann S
Ann Nucl Med; 2012 Jan; 26(1):77-85. PubMed ID: 22006540
[TBL] [Abstract][Full Text] [Related]
31. Hybrid SPECT-CT and PET-CT imaging of differentiated thyroid carcinoma.
Wong KK; Zarzhevsky N; Cahill JM; Frey KA; Avram AM
Br J Radiol; 2009 Oct; 82(982):860-76. PubMed ID: 19433487
[TBL] [Abstract][Full Text] [Related]
32. Value of ¹³¹I SPECT/CT for the evaluation of differentiated thyroid cancer: a systematic review of the literature.
Xue YL; Qiu ZL; Song HJ; Luo QY
Eur J Nucl Med Mol Imaging; 2013 May; 40(5):768-78. PubMed ID: 23242250
[TBL] [Abstract][Full Text] [Related]
33. The role of FDG-PET/CT in differentiated thyroid cancer patients with negative iodine-131 whole-body scan and elevated anti-Tg level.
Asa S; Aksoy SY; Vatankulu B; Aliyev A; Uslu L; Ozhan M; Sager S; Halac M; Sonmezoglu K
Ann Nucl Med; 2014 Dec; 28(10):970-9. PubMed ID: 25120245
[TBL] [Abstract][Full Text] [Related]
34. Detection of subcentimeter metastatic cervical lymph node by 18F-FDG PET/CT in patients with well-differentiated thyroid carcinoma and high serum thyroglobulin but negative 131I whole-body scan.
Kunawudhi A; Pak-art R; Keelawat S; Tepmongkol S
Clin Nucl Med; 2012 Jun; 37(6):561-7. PubMed ID: 22614187
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic value of ⁹⁹mTc-MDP SPECT/spiral CT in assessing indeterminate spinal solitary lesion of patients without malignant history.
Jiang L; Han L; Tan H; Hu P; Zhang Y; Shi H
Ann Nucl Med; 2013 Jun; 27(5):460-7. PubMed ID: 23459868
[TBL] [Abstract][Full Text] [Related]
36. The value of simultaneous co-registration of 99mTc- MDP and 131Iodine in metastatic differentiated thyroid carcinoma.
Kotb MH; Omar W; El-Maghraby T; El-Bedwihy M; El-Tawdy M; Mustafa H; Al-Nahhas A
Nucl Med Rev Cent East Eur; 2007; 10(2):98-105. PubMed ID: 18228214
[TBL] [Abstract][Full Text] [Related]
37. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.
Spanu A; Solinas ME; Farris A; Arru A; Chessa F; Madeddu G; Falchi A; Madeddu G
Radiol Med; 2004; 107(1-2):113-27. PubMed ID: 15031703
[TBL] [Abstract][Full Text] [Related]
38. SPECT/CT in patients with lower back pain after lumbar fusion surgery.
Sumer J; Schmidt D; Ritt P; Lell M; Forst R; Kuwert T; Richter R
Nucl Med Commun; 2013 Oct; 34(10):964-70. PubMed ID: 23820764
[TBL] [Abstract][Full Text] [Related]
39. Role of [(18)F]-fluorodeoxy-D-glucose positron emission tomography and computed tomography in the early detection of persistent/recurrent thyroid carcinoma in intermediate-to-high risk patients following initial radioactive iodine ablation therapy.
Kim MH; O JH; Ko SH; Bae JS; Lim DJ; Kim SH; Baek KH; Lee JM; Kang MI; Cha BY; Lee KW
Thyroid; 2012 Feb; 22(2):157-64. PubMed ID: 22224820
[TBL] [Abstract][Full Text] [Related]
40. 99mTc-Methylene diphosphonate SPECT/CT as the one-stop imaging modality for the diagnosis of osteoid osteoma.
Sharma P; Mukherjee A; Karunanithi S; Nadarajah J; Gamanagatti S; Khan SA; Bal C; Kumar R
Nucl Med Commun; 2014 Aug; 35(8):876-83. PubMed ID: 24751704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
